The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.

The EMA’s human medicines advisory committee has recommended approval of Eli Lilly’s Baqsimi as the first needle-free treatment for severe low blood sugar levels (hypoglycaemia) in diabetics ...

The resources are part of a nationwide collaboration between Lilly and the American Diabetes Association to destigmatize obesity and encourage stigma-free obesity care. “It’s time to recognize obesity ...

Eli Lilly has followed Novo Nordisk in announcing a big investment in its manufacturing network, intended to meet anticipated strong future demand for diabetes and obesity drugs. The pharma group ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The keto diet is a potentially helpful way for people with diabetes to manage blood sugar levels. This diet greatly restricts ... Most strips come with a color chart that you will use to compare your ...

At close: 7 February at 4:59:41 pm GMT-3 ...

Pre-market: 5:24:59 am GMT-5 ...